These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 23346282)
1. Oxidative stress in cardiovascular pathologies: genetics, cellular, and molecular mechanisms and future antioxidant therapies. Manea A; Fortuno A; Martin-Ventura JL Oxid Med Cell Longev; 2012; 2012():373450. PubMed ID: 23346282 [No Abstract] [Full Text] [Related]
2. Oxidative stress and antioxidant strategies in cardiovascular disease. Belló-Klein A; Khaper N; Llesuy S; Vassallo DV; Pantos C Oxid Med Cell Longev; 2014; 2014():678741. PubMed ID: 25031784 [No Abstract] [Full Text] [Related]
3. Mitochondrial redox status as a target for cardiovascular disease. Walters JW; Amos D; Ray K; Santanam N Curr Opin Pharmacol; 2016 Apr; 27():50-5. PubMed ID: 26894468 [TBL] [Abstract][Full Text] [Related]
4. Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders. Kim HK; Han J Adv Exp Med Biol; 2017; 982():621-646. PubMed ID: 28551810 [TBL] [Abstract][Full Text] [Related]
5. The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress. Skibska B; Goraca A Oxid Med Cell Longev; 2015; 2015():313021. PubMed ID: 25949771 [TBL] [Abstract][Full Text] [Related]
6. Immune, Inflammatory, and Oxidative Responses in Cardiovascular Complications. Ramana KV; Srivastava S; Reddy AB Oxid Med Cell Longev; 2016; 2016():6858402. PubMed ID: 27119008 [No Abstract] [Full Text] [Related]
7. Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction. Berlanga J; Cibrian D; Guevara L; Dominguez H; Alba JS; Seralena A; Guillén G; López-Mola E; López-Saura P; Rodriguez A; Perez B; Garcia D; Vispo NS Clin Sci (Lond); 2007 Feb; 112(4):241-50. PubMed ID: 16989643 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of melatonin in cardiovascular disease. Reiter RJ; Tan DX; Paredes SD; Fuentes-Broto L Ann Med; 2010 May; 42(4):276-85. PubMed ID: 20455793 [TBL] [Abstract][Full Text] [Related]
9. Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state. Dong R; Xu X; Li G; Feng W; Zhao G; Zhao J; Wang DW; Tu L PLoS One; 2013; 8(10):e77034. PubMed ID: 24204728 [TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart. Qin F; Siwik DA; Lancel S; Zhang J; Kuster GM; Luptak I; Wang L; Tong X; Kang YJ; Cohen RA; Colucci WS J Am Heart Assoc; 2013 Aug; 2(4):e000184. PubMed ID: 23963753 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician. Montezano AC; Touyz RM Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098 [TBL] [Abstract][Full Text] [Related]
13. Protective effect of antioxidant Tempol on cardiac stem cells in chronic pressure overload hypertrophy. Saheera S; Potnuri AG; Nair RR Life Sci; 2019 Apr; 222():88-93. PubMed ID: 30822425 [TBL] [Abstract][Full Text] [Related]
14. Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis. Wang XL; Wang X; Xiong LL; Zhu Y; Chen HL; Chen JX; Wang XX; Li RL; Guo ZY; Li P; Jiang W J Cardiovasc Pharmacol; 2013 Dec; 62(6):512-23. PubMed ID: 24072175 [TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV Prevents Cardiac Remodeling in the Apolipoprotein E-Deficient Mice by Regulating Cardiac Homeostasis and Oxidative Stress. Li XZ; Ding YZ; Wu HF; Bian ZP; Xu JD; Gu CR; Chen XJ; Yang D Cell Physiol Biochem; 2017; 44(6):2422-2438. PubMed ID: 29268252 [TBL] [Abstract][Full Text] [Related]
16. Tetrahydrobiopterin: a vascular redox target to improve endothelial function. Channon KM Curr Vasc Pharmacol; 2012 Nov; 10(6):705-8. PubMed ID: 23259560 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular protection by curcumin: molecular aspects. Kapakos G; Youreva V; Srivastava AK Indian J Biochem Biophys; 2012 Oct; 49(5):306-15. PubMed ID: 23259317 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases. Subramanian S; Kalyanaraman B; Migrino RQ Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):54-65. PubMed ID: 19807685 [TBL] [Abstract][Full Text] [Related]
19. Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity. Farkhondeh T; Samarghandian S Cardiovasc Hematol Disord Drug Targets; 2016; 16(1):30-37. PubMed ID: 27492624 [TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome. Balderas-Villalobos J; Molina-Muñoz T; Mailloux-Salinas P; Bravo G; Carvajal K; Gómez-Viquez NL Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1344-53. PubMed ID: 23997093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]